Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apitox vs Histamine in Knee Osteoarthritis
NCT01112722Phase 3Completed
- Sponsor
- Apimeds Pharmaceuticals US, Inc.
- Start
- Dec 2013
- Primary completion
- Nov 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of apis mellifera venom in knee osteoarthritis (OA), sponsored by Apimeds Pharmaceuticals US, Inc.. Started Dec 2013; status: completed.
02
Drugs
apis mellifera venom
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01112722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01112722.